Skip to main content
Aarti Pharmalabs Limited (NSE:AARTIPHARM)
India flag India · Delayed Price · Currency is INR
730.35
-4.80 (-0.65%)
Apr 28, 2025, 3:29 PM IST

Aarti Pharmalabs Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
Net Income
-2,1691,9351,223-0.05-0.19
Depreciation & Amortization
-732.35625.43421.19--
Loss (Gain) From Sale of Assets
--5.514.47-0.4--
Provision & Write-off of Bad Debts
-10.6815---
Other Operating Activities
-475.51237.64223.3--
Change in Accounts Receivable
--1,255-351.72-1,0250.05-
Change in Inventory
--396.64-1,267-559.92--
Change in Accounts Payable
-433.481,302-718.62--
Operating Cash Flow
-2,1642,501-437.04--0.19
Operating Cash Flow Growth
--13.50%----
Capital Expenditures
--1,556-1,021-1,412--
Sale (Purchase) of Intangibles
--431.81-175.29---
Investment in Securities
--188.53-391.23-0.73--
Other Investing Activities
-30.749.7724.86--
Investing Cash Flow
--2,146-1,578-1,387--
Short-Term Debt Issued
-499.94-2,723--
Long-Term Debt Issued
-----0.19
Total Debt Issued
-499.94-2,723-0.19
Short-Term Debt Repaid
---1,243---
Long-Term Debt Repaid
--49.3----
Total Debt Repaid
--49.3-1,243---
Net Debt Issued (Repaid)
-450.64-1,2432,723-0.19
Issuance of Common Stock
-----2.5
Common Dividends Paid
--181.25-181.25---
Other Financing Activities
--172.15-210.52-119.59--
Financing Cash Flow
-97.24-1,6352,604-2.69
Miscellaneous Cash Flow Adjustments
-0----
Net Cash Flow
-115.14-711.52779.41-2.5
Free Cash Flow
-607.51,480-1,849--0.19
Free Cash Flow Growth
--58.95%----
Free Cash Flow Margin
-3.28%7.61%-15.40%--
Free Cash Flow Per Share
-6.7016.33-20.40--0.75
Cash Interest Paid
-172.15210.523.4--
Cash Income Tax Paid
-569.37623.83211.29--
Levered Free Cash Flow
--521.96940.76-6,998--
Unlevered Free Cash Flow
--414.371,072-6,995--
Change in Net Working Capital
-1,116103.467,035--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.